This study tests an experimental treatment called ACI-7104.056 in 150 people with early-stage Parkinson's disease. The goal is to see if it is safe and can help control the disease by targeting a protein linked to Parkinson's. Participants receive either the treatment or a placeb…
Phase: PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC